Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, gives the keynote address “Ketamine for Suicidal Depression: The Benefits are Clear, but so are the Risks.” Sachs Neuroscience Innovation Forum in San Francisco, CA on January 7, 2024.
VIDEO
CORPORATE PRESENTATION | JANUARY 2024
